ACTRN12607000090415尚未招募2 期
Phase II Trial of Temozolomide and Caelyx in the Treatment of Patients with Glioblastoma Multiforme following concurrent radiotherapy and chemotherapy to improve six month progression free survival
Schering-Plough0 个研究点目标入组 40 人开始时间: 2007年1月29日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Inclusion: Newly diagnosed glioblastoma, performance status 0-2, completed post-operative concurrent radiotherapy/chemotherapy.
排除标准
- •Exclusion: significant co-morbidities
研究者
相似试验
进行中（未招募）
不适用
A Phase II study of Temozolomide (Temodal) Given Continously 100mg/m2 for 21 Days in 28 Day cycles in Patients with Metastatic Melanoma.Metastatic melanomaEUCTR2004-002925-39-SEKliniken för onkologi, Karolinska Universitetssjukhuset, Solna35
进行中（未招募）
不适用
PHASE 2 SINGLE- ARM STUDIES OF TEMOZOLOMIDE IN COMBINATION WITH TOPOTECANIN REFRACTORY AND RELAPSED NEUROBLASTOMA AND OTHER PAEDIATRIC SOLID TUMOURS - TOTEM 2EUROBLASTOMA AND OTHER PAEDIATRIC SOLID TUMOURSMedDRA version: 9.1Level: PTClassification code 10029260MedDRA version: 9.1Level: PTClassification code 10039491EUCTR2009-012644-16-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI93
进行中（未招募）
不适用
Phase 2 single-arm studies of Temozolomide in combination with Topotecan in refractory or relapsing Neuroblastoma and Other pediatric solid tumours. - ITCC 013 - TOTEM2euroblastoma and Other pediatric solid tumours.MedDRA version: 9.1Level: LLTClassification code 10066595Term: Neuroblastoma recurrentEUCTR2008-001436-12-ATInstitut Gustave Roussy93
进行中（未招募）
不适用
Phase 2 single-arm studies of Temozolomide in combination with Topotecan in refractory or relapsing Neuroblastoma and Other pediatric solid tumours. - ITCC 013 - TOTEM2euroblastoma and Other pediatric solid tumours.MedDRA version: 9.1Level: LLTClassification code 10066595Term: Neuroblastoma recurrentEUCTR2008-001436-12-FRInstitut Gustave Roussy125
进行中（未招募）
不适用
Phase 2 single-arm studies of Temozolomide in combination with Topotecan in refractory or relapsing Neuroblastoma and Other pediatric solid tumours. - ITCC 013 - TOTEM2EUCTR2008-001436-12-NLInstitut Gustave Roussy93